| scholarly article | Q13442814 |
| P2093 | author name string | Nakamura T | |
| Mizuno K | |||
| Gallagher JT | |||
| Lyon M | |||
| Deakin JA | |||
| P433 | issue | 15 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 8 | |
| P304 | page(s) | 11216-11223 | |
| P577 | publication date | 1994-04-01 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Interaction of hepatocyte growth factor with heparan sulfate. Elucidation of the major heparan sulfate structural determinants | |
| P478 | volume | 269 |
| Q28484582 | A New C-Xyloside Induces Modifications of GAG Expression, Structure and Functional Properties |
| Q36030047 | A connective tissue growth factor signaling receptor in corneal fibroblasts |
| Q28592424 | A novel mechanism of sequestering fibroblast growth factor 2 by glypican in lipid rafts, allowing skeletal muscle differentiation |
| Q41903254 | Activin A Binds to Perlecan through Its Pro-region That Has Heparin/Heparan Sulfate Binding Activity |
| Q27690294 | An allosteric switch for pro-HGF/Met signaling using zymogen activator peptides |
| Q24561588 | An uncleavable form of pro-scatter factor suppresses tumor growth and dissemination in mice |
| Q38353503 | Binding of endostatin to endothelial heparan sulphate shows a differential requirement for specific sulphates. |
| Q42024555 | Biochemical characterization of the chondroitinase ABC I active site |
| Q36924083 | Clinical impact of real-time evaluation of the biological activity and degradation of hepatocyte growth factor |
| Q35010790 | Clinicopathological significance of heparanase and basic fibroblast growth factor expression in human esophageal cancer |
| Q28348093 | Combined strong anion-exchange HPLC and PAGE approach for the purification of heparan sulphate oligosaccharides |
| Q27635335 | Crystal structures of NK1-heparin complexes reveal the basis for NK1 activity and enable engineering of potent agonists of the MET receptor. |
| Q38309124 | Detection of oligosaccharide ligands for hepatocyte growth factor/scatter factor (HGF/SF), keratinocyte growth factor (KGF/FGF-7), RANTES and heparin cofactor II by neoglycolipid microarrays of glycosaminoglycan-derived oligosaccharide fragments |
| Q37064535 | Diaphragm adaptations in patients with COPD. |
| Q92855878 | Distinct Localization of Mature HGF from its Precursor Form in Developing and Repairing the Stomach |
| Q38309783 | Effect of heparin and liver heparan sulphate on interaction of HepG2-derived transcription factors and their cis-acting elements: altered potential of hepatocellular carcinoma heparan sulphate |
| Q33794185 | Effective inhibition of c-MET-mediated signaling, growth and migration of ovarian cancer cells is influenced by the ovarian tissue microenvironment |
| Q36332838 | Endothelial heparan sulfate 6-O-sulfation levels regulate angiogenic responses of endothelial cells to fibroblast growth factor 2 and vascular endothelial growth factor. |
| Q35050525 | Epigenetic inactivation of heparan sulfate (glucosamine) 3-O-sulfotransferase 2 in lung cancer and its role in tumorigenesis |
| Q33897755 | Extended N-sulfated domains reside at the nonreducing end of heparan sulfate chains. |
| Q57791826 | Extracellular Matrix Influencing HGF/c-MET Signaling Pathway: Impact on Cancer Progression |
| Q35286204 | Fetal growth restriction and hepatocyte growth factor |
| Q30581656 | Four individually druggable MET hotspots mediate HGF-driven tumor progression. |
| Q41953959 | Glypican-1 regulates myoblast response to HGF via Met in a lipid raft-dependent mechanism: effect on migration of skeletal muscle precursor cells |
| Q24541580 | HSulf-2, an extracellular endoglucosamine-6-sulfatase, selectively mobilizes heparin-bound growth factors and chemokines: effects on VEGF, FGF-1, and SDF-1. |
| Q35219652 | Heparan sulfate 2-O-sulfotransferase (Hs2st) and mouse development. |
| Q35059448 | Heparan sulfate proteoglycans |
| Q77324114 | Heparin and enoxaparin enhance endotoxin-induced tumor necrosis factor-alpha production in human monocytes |
| Q42002922 | Heparin binding to platelet factor-4. An NMR and site-directed mutagenesis study: arginine residues are crucial for binding |
| Q39785077 | Heparin regulates colon cancer cell growth through p38 mitogen-activated protein kinase signalling |
| Q38418286 | Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use. |
| Q92152542 | Heparinoid Complex-Based Heparin-Binding Cytokines and Cell Delivery Carriers |
| Q88881173 | Hepatocyte growth factor and epidermal growth factor activity during later stages of rat liver regeneration upon interferon α-2b influence |
| Q39539848 | Herpes simplex virus types 1 and 2 differ in their interaction with heparan sulfate. |
| Q40250657 | Identification of core active disaccharides in heparin for HGF-inducing activity |
| Q47878776 | Inhibition of DNA topoisomerase I activity by heparan sulfate and modulation by basic fibroblast growth factor. |
| Q37811895 | MET signalling: principles and functions in development, organ regeneration and cancer |
| Q30446159 | Met-Independent Hepatocyte Growth Factor-mediated regulation of cell adhesion in human prostate cancer cells |
| Q37560675 | Multifunctionality of extracellular and cell surface heparan sulfate proteoglycans |
| Q38343547 | Multiple mechanisms for exogenous heparin modulation of vascular endothelial growth factor activity |
| Q36889781 | NMR solution conformation of heparin-derived hexasaccharide |
| Q42983336 | NMR solution conformation of heparin-derived tetrasaccharide |
| Q28345285 | Normal and malignant prostate epithelial cells differ in their response to hepatocyte growth factor/scatter factor |
| Q42799009 | Plasminogen-mediated activation and release of hepatocyte growth factor from extracellular matrix |
| Q90239120 | Polyelectrolyte Complexes of Natural Polymers and Their Biomedical Applications |
| Q38181492 | Post-Synthetic Regulation of HS Structure: The Yin and Yang of the Sulfs in Cancer |
| Q38782345 | Preclinical and clinical evaluation of MET functions in cancer cells and in the tumor stroma. |
| Q26772304 | Proteoglycans in liver cancer |
| Q34362776 | Proteoglycans: pericellular and cell surface multireceptors that integrate external stimuli in the mammary gland |
| Q39155470 | Quantitative Phosphoproteomics Analysis Reveals Broad Regulatory Role of Heparan Sulfate on Endothelial Signaling |
| Q42947434 | Regulation of cytokine signaling by B cell antigen receptor and CD40-controlled expression of heparan sulfate proteoglycans |
| Q28589603 | Renal agenesis in mice homozygous for a gene trap mutation in the gene encoding heparan sulfate 2-sulfotransferase |
| Q42742727 | Role of 6-O-sulfated heparan sulfate in chronic renal fibrosis. |
| Q77571474 | Role of hepatocyte growth factor and its receptor c-met in multiple myeloma |
| Q39262254 | SULF1 inhibits proliferation and invasion of esophageal squamous cell carcinoma cells by decreasing heparin-binding growth factor signaling |
| Q38674666 | Semi-synthesis of a HGF/SF kringle one (K1) domain scaffold generates a potent in vivo MET receptor agonist. |
| Q38325522 | Sequence analysis of heparan sulphate and heparin oligosaccharides |
| Q58615784 | Suppressive effect of syndecan ectodomains and N-desulfated heparins on osteoclastogenesis via direct binding to macrophage-colony stimulating factor |
| Q40412665 | Syndecan family of cell surface proteoglycans: developmentally regulated receptors for extracellular effector molecules |
| Q24530478 | Syndecans: multifunctional cell-surface co-receptors |
| Q55331907 | Targeting Heparan Sulfate Proteoglycans as a Novel Therapeutic Strategy for Mucopolysaccharidoses. |
| Q38290246 | The "in and out" of glucosamine 6-O-sulfation: the 6th sense of heparan sulfate. |
| Q40794888 | The antifibrotic effects of plasminogen activation occur via prostaglandin E2 synthesis in humans and mice |
| Q41063796 | The development of the kidney. |
| Q35096108 | The plasminogen activation system reduces fibrosis in the lung by a hepatocyte growth factor-dependent mechanism |
| Q38614156 | Tropism-modification strategies for targeted gene delivery using adenoviral vectors |
Search more.